Loading...

SISI SHINECO INC Company Mergers 8-K Filing

SHNC

SS

SHINECO INC

(SISI)

2023 8-K

Show Summary

Show Summary

Asset Acquisitions

Asset Acquisitions

Forced Delisting

Equity Offerings

Asset Acquisitions

Asset Acquisitions

Asset Acquisitions

Stock Purchase Agreement

Share Sale Agreement

Director Changes

Nasdaq Compliance

Stock Split Approved

Stock Split Approved

Underwriting Agreement for ...

Distribution Agreements

Unregistered Sales of Equit...

Compliance regained with Na...

Securities Purchase Agreement

Compensation Waiver

Compliance Regained with Na...

Annual Meeting Results

Amendment to Offering and C...

Securities Purchase Agreement

Lawsuit Discontinuation

Bylaws Amendment

Acquisition Completion

Completion of Acquisition o...

Annual Meeting Results

Agreements with Non-U.S. In...

Acquisition of Wintrus

Acquisition of Dream Ltd.

Completion of Acquisition

External Links:

Shineco, Inc. completed the acquisition of 51% equity interests of Changzhou Biowin Pharmaceutical Co., Ltd. for $9 million in cash and 3,260,000 shares of common stock.

AI Assistant

SHINECO INC

2023

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.